This week’s discussions were disrupted by the ID team. No coincidence, I think, that the rheumatology discussion was subverted to ID. All part of the greater conspiracy? Next they will be claiming that rheumatoid arthritis is an infection.Perhaps those who did not have opportunity to present will post some brief comments? Dr Joshi’s exposition on the safe use of sulfasalazine was well designed and practical, especially his final paragraph about responding to problems.
We will have to discuss the homeless man on another occasion.
For next week I have chosen neutral ground, neither primarily ID nor Rheumatology: Venous thromboembolism…assignments as below, though you may swap uif you see fit. If your name does not appear you can still do two minutes on an aspect of VTE.
Epidemiology (CC)
Investigation (VJ)
Treatment (AC)
Prognosis
Remember, only two minutes...keep it concise yet precise...quote your sources.
The paper for discussion is from the parliamentary ombudsman and relates to case 200501128
Read and think….have something to say.
Interesting topics this week
Thrombocythaemia
HOCM
MJM
1 comment:
Azathioprine should be introduced by specialists only and clear guidelines regarding monitoring agreed with the GP. This invloves weekly monitoring of FBC for 6 weeks then monthly as well as monthly LFT and ESR.
As with all DMARDS, patient education is paramount- patients should be aware they need to stop the medication and seek medical advice within 24 hours of developing a sore throat, possible infection or rash/uneplained bruising.
Post a Comment